Spain already manufactures one of the most revolutionary anti-obesity drugs, but patients from the Canary Islands and the rest of the national territory will still have to wait to access it. The pharmaceutical plant Lilly in Alcobendas (Madrid) has begun to produce orforglipron, an oral pill that will be exported to 120 countries. At the moment, the drug – traded under the name of Fondayo – is authorized in the United States, the United Arab Emi…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Spain already manufactures one of the most revolutionary anti-obesity drugs, but patients from the Canary Islands and the rest of the national territory will still have to wait to access it. The pharmaceutical plant Lilly in Alcobendas (Madrid) has begun to produce orforglipron, an oral pill that will be exported to 120 countries. At the moment, the drug – traded under the name of Fondayo – is authorized in the United States, the United Arab Emi…